Jacob Schulman

Encapsulating Synthetic STING Agonist, MSA-2, in Endosomolytic Polymersomes for Cancer Immunotherapy

Utilization of STING agonist MSA-2 encapsulated nanocarriers to enhance the immune system’s ability to eliminate cancer cells.
Synthesis and Characterization of Macromolecular Polymeric STING Agonists for Cancer Immunotherapy Applications

Incorporating STING agonists into polymeric delivery systems as an alternative cancer treatment.